Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

PURPOSE: A detailed analysis of hepatitis C virus (HCV) resistance-associated substitutions (RASs) is required to understand why people fail direct-acting antiviral therapies. This study was conducted to assess RASs in an analysis of 2 trials evaluating the second-generation NS3/4A protease inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonsall, David, Black, Stuart, Howe, Anita YM, Chase, Robert, Ingravallo, Paul, Pak, Irene, Brown, Anthony, Smith, David A, Bowden, Rory, Barnes, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089106/
https://www.ncbi.nlm.nih.gov/pubmed/30127629
http://dx.doi.org/10.2147/IDR.S156581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089106/
https://www.ncbi.nlm.nih.gov/pubmed/30127629
http://dx.doi.org/10.2147/IDR.S156581

Ejemplares similares